424 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
9.1 | DF | IN VIVO DIAGNOSIS OR IN VIVO TESTING {7} |
9.3 | DF | .~ Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) {7} |
9.35 | | .~.~ Carbohydrate or derivative thereof attached to or complexed with the agent {1} |
9.351 | DF | .~.~.~> The region of the imaging agent responsibile for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids |